title: Management of ovarian cancer in the renal transplant recipient with cyclophosphamide used as an immunosuppressive and antineoplastic agent.
authors.affiliation: Intensive Care Unit, Institut Gustave-Roussy, Villejuif, France.
authors.forename: F
authors.initials: F
authors.lastname: Vincent
authors.forename: M
authors.initials: M
authors.lastname: Michel
authors.forename: A C
authors.initials: AC
authors.lastname: Marrast
authors.forename: T A
authors.initials: TA
authors.lastname: Bensousan
authors.forename: D
authors.initials: D
authors.lastname: Glotz
authors.forename: A
authors.initials: A
authors.lastname: Duboust
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy*; D007690:Polycystic Kidney Diseases / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide